To Sponsor and Participate in Be The Match® Walk+Run to Raise Awareness for Bone Marrow Transplant

NEW YORK - September 26, 2016 (Investorideas.com Newswire) Actinium Pharmaceuticals, Inc. (NYSE: ATNM)("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that the Company has sponsored and will participate in the upcoming Be The Match® Walk+Run being held on Saturday, October 1, 2016, at Firefighter's Field on Roosevelt Island, New York, New York. The goal of the Walk+Run is to raise awareness for bone marrow transplant (BMT), raise funds to help transplant patients, support marrow transplant research and add more potential marrow donors to the Be The Match Registry®.

Employees of Actinium Pharmaceuticals, together with their family and friends, will be participating in the Be The Match® Walk+Run to raise awareness and funds. To support Team Actinium and Be The Match® , please visit Actinium's team page here: Click here to view the team page for Team Actinium

Read more: Actinium Pharmaceuticals ( ATNM )

Acquisition will strengthen and add scale to current functional services offering to meet growing demand

London, UK: September 26, 2016 –PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that the Company has entered into a definitive agreement to acquire ExecuPharm, Inc. (“ExecuPharm”), a leading, global functional service provider (FSP) serving the biopharmaceutical industry. The acquisition is expected to close in the next three weeks. Terms of the transaction were not disclosed.

Established in 1995, ExecuPharm provides clients with qualified professionals across functional areas, such as clinical monitoring or study management, along with associated operational activities including onboarding, training, line management, performance management and policy administration. The company is headquartered in King of Prussia, PA, and it works with many of the top 20 and mid-sized and small biopharmaceutical companies. ExecuPharm’s strong client relationships have led to 85 percent growth in the company in the past three years.

Read more: PAREXEL Announces Execution Of Definitive Agreement To Acquire ExecuPharm

Facebook Inc (NASDAQ:FB) will be under $100 by the end of the year. Analysts are beginning to buzz about some of the news that has hit the stock lately. Just today, it broke that Facebook had over estimated key video metrics for two years. The stock is sharply lower. This is just one more nail the the coffin. The biggest one came a month ago when Procter & Gamble Co (NYSE:PG), the biggest spender on advertising in the world said they were moving away from highly targeted Facebook ads. Let me repeat, the BIGGEST ADVERTISING SPENDER IN THE WORLD said this. 

Now imagine all the other companies that heard that news and are experiencing the same poor results. Facebook was all the rage over the last few years but the honest truth is, many companies are experiencing a loss when they spend on targeted Facebook ads. People are immune to ads.

Read more: Facebook Will Be Under $100 By End Of Year On Alarming Cutback In Targeted Ad Spend

Point Roberts, WA, Delta BC – September 23, 2016 – Investorideas.com, a global news source and investor resource issues a sector news snapshot for the mining sector. Recent news in September from companies currently mining in Mexico include Endeavour Silver Corp. (NYSE: EXK) (TSX: EDR), Gainey Capital Corp. (TSXV: GNC; OTCQX: GNYPF), Pan American Silver Corp. (NASDAQ: PAAS) (TSX: PAA) and SilverCrest Metals Inc. (TSXV: SIL.V).

Read this release in full at http://www.investorideas.com/news/2016/mining/09232Mexico.asp

Endeavour Silver Corp. (NYSE: EXK) (TSX: EDR) announced it entered into a definitive agreement dated September 13, 2016 (the "Agreement") with Silver Standard Resources Inc. to acquire a 100% interest in Silver Standard's Parral properties, located in the historic silver mining district of Hidalgo de Parral in southern Chihuahua state, Mexico.

Pursuant to the Agreement, Endeavour will pay US$6 million in Endeavour common shares, being 1,198,083 common shares at US$5.008 per share, representing the 10-day average closing price of Endeavour's shares on the New York Stock Exchange ("NYSE") prior to the date of the Agreement.

Read more: Sector News Snapshot; #Mining in Mexico; (TSX: $EDR), (TSXV: $GNC), (TSX: $PAA), (TSXV: $SIL.V)

I rarely get good information from my sources. I usually rely on studying the stock charts and doing research into companies myself. This time it is different. A well known Wall Street insider who I have looked at as an idol, showed me the chart trend line seen below. I immediately shorted the Russell 2000. The expectation is for the pull back to begin next Monday according to him, but it may start as earlier as tomorrow. If you average the drops and pops off of that long term mega line, there should be at least a 5-7% correction/pullback in the $IWM. For those of you who are rockstar risk takers, you can always buy the $TZA for extra exposure.

Read more: Big Wall Street Insider Showed Me This: I Responded By Shorting The Russell 2000